Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism

Hypertension Research

Volumn 33, Issue 5, 2010, Pages 478-484

  Zhang, Guo Xi ^a,b   Wang, Bao Jun ^a   Ouyang, Jin Zhi ^a   Deng, Xi Yuan ^c   Ma, Xin ^a   Li, Hong Zhao ^a   Wu, Zhun ^d   Liu, Shuang Lin ^d   Xu, Hua ^d   Zhang, Xu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

^c Pingdingshan People's Hospital No 1   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CYP11B1; CYP11B2; PH; Polymorphism

Indexed keywords

ALDOSTERONE SYNTHASE; CYTOCHROME P450; CYTOCHROME P450 CYP11B1; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE CONVERSION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERALDOSTERONISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE SYNTHASE; ALLELES; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HYPERALDOSTERONISM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; STEROID 11-BETA-HYDROXYLASE;

EID: 77951964892     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.21     Document Type: Article

References (26)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281.
2. Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, Ohnishi T, Ichikawa Y, Nakao K, Imura H, Ulick S, Shizuta Y. Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorti-coids in humans. Proc Natl Acad Sci USA 1992; 89: 1458-1462.
3. Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC. The product of the cyp11b2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 1991; 5: 1513-1522.
4. Ferrari P, Bianchetti M, Frey FJ. Juvenile hypertension, the role of genetically altered steroid metabolism. Horm Res 2001; 55: 213-223.
5. Mornet E, Dupont J, Vitek A, White PC. Characterization of two genes encoding human steroid 11 beta-hydroxylase (p-450(11) beta). J Biol Chem 1989; 264: 20961-20967.
6. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene cyp11b2. Hypertension 1999; 33: 703-707.
7. Lim PO, Macdonald TM, Holloway C, Friel E, Anderson NH, Dow E, Jung RT, Davies E, Fraser R, Connell JM. Variation at the aldosterone synthase (cyp11b2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J Clin Endocrinol Metab 2002; 87: 4398-4402.
8. Nicod J, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P. A biallelic gene polymorphism of cyp11b2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 2003; 88: 2495-2500.
9. Barr M, MacKenzie SM, Friel EC, Holloway CD, Wilkinson DM, Brain NJ, Ingram MC, Fraser R, Brown M, Samani NJ, Caulfield M, Munroe PB, Farrall M, Webster J, Clayton D, Dominiczak AF, Connell JM, Davies E. Polymorphic variation in the 11beta-hydro-xylase gene associates with reduced 11-hydroxylase efficiency. Hypertension 2007; 49: 113-119.
10. Imrie H, Freel M, Mayosi BM, Davies E, Fraser R, Ingram M, Cordell HJ, Farrall M, Avery PJ, Watkins H, Keavney B, Connell JM. Association between aldosterone production and variation in the 11beta-hydroxylase (cyp11b1) gene. J Clin Endocrinol Metab 2006; 91: 5051-5056.
11. Inglis GC, Plouin PF, Friel EC, Davies E, Fraser R, Connell JM. Polymorphic differences from normal in the aldosterone synthase gene (cyp11b2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome). Clin Endocrinol (Oxf) 2001; 54: 725-730.
12. Tanahashi H, Mune T, Takahashi Y, Isaji M, Suwa T, Morita H, Yamakita N, Yasuda K, Deguchi T, White PC, Takeda J. Association of lys173arg polymorphism with cyp11b2 expression in normal adrenal glands and aldosterone-producing adenomas. J Clin Endocrinol Metab 2005; 90: 6226-6231.
13. Mulatero P, Schiavone D, Fallo F, Rabbia F, Pilon C, Chiandussi L, Pascoe L, Veglio F. Cyp11b2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension 2000; 35: 694-698.
14. Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, Boscaro M, Sonino N, Fallo F. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab 1998; 83: 2573-2575.
15. Holland OB, Brown H, Kuhnert L, Fairchild C, Risk M, Gomez-Sanchez CE. Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 1984; 6: 717-723.
16. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045-1050.
17. Ganapathipillai S, Laval G, Hoffmann IS, Castejon AM, Nicod J, Dick B, Frey FJ, Frey BM, Cubeddu LX, Ferrari P. Cyp11b2-cyp11b1 haplotypes associated with decreased 11 beta-hydroxylase activity. J Clin Endocrinol Metab 2005; 90: 1220-1225.
18. White P, Slutsker L. Haplotype analysis of cyp11b2. Endocr Res 1995; 21: 437-442.
19. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97: 10483-10488.
20. Keavney B, Mayosi B, Gaukrodger N, Imrie H, Baker M, Fraser R, Ingram M, Watkins H, Farrall M, Davies E, Connell J. Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. J Clin Endocrinol Metab 2005; 90: 1072-1077.
21. Freel EM, Ingram M, Wallace AM, White A, Fraser R, Davies E, Connell JM. Effect of variation in cyp11b1 and cyp11b2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects. Clin Endo-crinol (Oxf) 2008; 68: 700-706.
22. Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies E, Shakerdi L, Wallace AM, Fraser R, Connell JM. Aldosterone synthase gene variation and adreno-cortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clin Endocrinol (Oxf) 2004; 61: 174-181.
23. Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, Kinoshita M, Mannami T, Ogata J, Baba S. Lack of association between genetic polymorphism of cyp11b2 and hypertension in japanese: the Suita Study. Hypertens Res 2001; 24: 105-109.
24. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 1998; 11: 856-860.
25. Yamagishi K, Tanigawa T, Cui R, Tabata M, Ikeda A, Yao M, Shimamoto T, Iso H. Aldosterone synthase gene T-344C polymorphism, sodium and blood pressure in a free-living population: a community-based study. Hypertens Res 2007; 30: 497-502.
26. Kumar NN, Benjafield AV, Lin RC, Wang WY, Stowasser M, Morris BJ. Haplotype analysis of aldosterone synthase gene (cyp11b2) polymorphisms shows association with essential hypertension. J Hypertens 2003; 21: 1331-1337.